首页> 外文期刊>Trials >Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferences
【24h】

Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferences

机译:通过研究患者的治疗偏好,对招募人员进行随机试验培训,以促进招募和知情同意

获取原文
获取外文期刊封面目录资料

摘要

Background Patients’ treatment preferences are often cited as barriers to recruitment in randomized controlled trials (RCTs). We investigated how RCT recruiters reacted to patients’ treatment preferences and identified key strategies to improve informed decision-making and trial recruitment. Methods Audio-recordings of 103 RCT recruitment appointments with 96 participants in three UK multicenter pragmatic RCTs were analyzed using content and thematic analysis. Recruiters’ responses to expressed treatment preferences were assessed in one RCT (ProtecT - Prostate testing for cancer and Treatment) in which training on exploring preferences had been given, and compared with two other RCTs where this specific training had not been given. Results Recruiters elicited treatment preferences similarly in all RCTs but responses to expressed preferences differed substantially. In the ProtecT RCT, patients’ preferences were not accepted at face value but were explored and discussed at length in three key ways: eliciting and acknowledging the preference rationale, balancing treatment views, and emphasizing the need to keep an open mind and consider all treatments. By exploring preferences, recruiters enabled participants to become clearer about whether their views were robust enough to be sustained or were sufficiently weak that participation in the RCT became possible. Conversely, in the other RCTs, treatment preferences were often readily accepted without further discussion or understanding the reasoning behind them, suggesting that patients were not given the opportunity to fully consider all treatments and trial participation. Conclusions Recruiters can be trained to elicit and address patients’ treatment preferences, enabling those who may not have considered trial participation to do so. Without specific guidance, some RCT recruiters are likely to accept initial preferences at face value, missing opportunities to promote more informed decision-making. Training interventions for recruiters that incorporate key strategies to manage treatment preferences, as in the ProtecT study, are required to facilitate recruitment and informed consent. Trial registration ProtecT RCT: Current Controlled Trials ISRCTN20141297 . The other two trials are registered but have asked to be anonymized.
机译:背景技术在随机对照试验(RCT)中,经常将患者的治疗偏好作为招募的障碍。我们调查了RCT招募人员对患者治疗偏好的反应,并确定了关键策略以改善知情决策和试验招募。方法采用内容分析法和主题分析法,对英国3个多中心实用RCT中103名RCT招聘人员的录音进行了分析。在一项RCT(ProtecT-癌症和治疗的前列腺测试)中评估了招聘人员对表达的治疗偏好的反应,在该RCT中已进行了探索偏好的培训,并与未进行此特定培训的另外两个RCT进行了比较。结果招聘者在所有RCT中均相似地引起治疗偏爱,但是对表达的偏爱的反应却存在显着差异。在ProtecT RCT中,患者的偏爱并没有从表面上接受,而是通过三种主要方式进行了详细探讨:引起和认可偏爱的基本原理,平衡治疗观点以及强调保持开放思想并考虑所有治疗的需要。通过探索偏好,招募人员使参与者能够更清楚地了解他们的观点是否足够牢固,可以维持或足够虚弱以至于可以参加RCT。相反,在其他RCT中,通常无需接受进一步讨论或理解其背后的原因,通常就容易接受治疗偏好,这表明患者没有机会充分考虑所有治疗方法和试验参与。结论可以对招聘人员进行培训,以引起和解决患者的治疗偏爱,使那些可能没有考虑参加试验的人也可以这样做。在没有具体指导的情况下,一些RCT招聘人员可能会从表面上接受最初的偏好,缺少机会来促进更明智的决策。如ProtecT研究中所要求的,针对招募人员的培训干预措施应结合关键策略来管理治疗偏好,以促进招募和知情同意。试用注册ProtecT RCT:现行对照试验ISRCTN20141297。其他两个试验已注册,但要求匿名。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号